COVID-19 Updates: Monoclonal Antibodies for COVID-19.

Med Lett Drugs Ther ; 64(1642): 16, 2022 01 24.

Article in English | MEDLINE | ID: covidwho-1678611

Subject(s)

Antibodies, Monoclonal, Humanized/therapeutic use; Antibodies, Monoclonal/therapeutic use; Antibodies, Neutralizing/therapeutic use; Antiviral Agents/therapeutic use; COVID-19 Drug Treatment; SARS-CoV-2/drug effects; Antibodies, Monoclonal/adverse effects; Antibodies, Monoclonal, Humanized/adverse effects; Antibodies, Neutralizing/adverse effects; Antiviral Agents/adverse effects; COVID-19/immunology; COVID-19/virology; Drug Combinations; Host-Pathogen Interactions; Humans; SARS-CoV-2/genetics; SARS-CoV-2/immunology; Treatment Outcome; United States

Keywords

REGEN-COV; bamlanivimab; casirivimab; etesevimab; imdevimab; sotrovimab

Search on Google

XML

PubMed Links

Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Antibodies, Neutralizing / Antibodies, Monoclonal, Humanized / SARS-CoV-2 / COVID-19 Drug Treatment / Antibodies, Monoclonal Type of study: Prognostic study Limits: Humans Country/Region as subject: North America Language: English Journal: Med Lett Drugs Ther Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML

PubMed Links